Given time, ongoing mutation of the SARS-COV2 virus is likely to produce a super-lineage, at least...
We evaluated 254 COVID-19 patients longitudinally from early infection and for eight months...
There are two clinical trials of monoclonal antibodies that target covid19.
AstraZeneca is...
#CLLSociety Pfizer and BioNTech’s big news this week of a promising novel (not "live") “RNA”...